Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

409
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
409
Hypoxia01:23

Hypoxia

1.4K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.4K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

253
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
253
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

879
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
879
Aging01:26

Aging

358
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
358
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

419
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
419

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a Humanized Anti-Fibrotic Antibody Targeting Extracellular Collagen Assembly to Reduce Post-Traumatic Scarring.

bioRxiv : the preprint server for biology·2026
Same author

Simulated Workflow Feasibility Evaluation of a Web-Based Periorbital Measurement Platform: Development and Usability Study.

JMIR human factors·2026
Same author

Alternate splicing converts human CD137 from costimulatory to immunosuppressive function.

Journal of autoimmunity·2025
Same author

Seroprevalence of dengue virus infection among febrile patients visiting healthcare facilities in the selected districts of Afar region, Northeast Ethiopia.

BMC infectious diseases·2025
Same author

Higher order receptor clustering due to the IgG3 subclass is necessary for TLR4 signaling and tolerance induction by novel human anti-TLR4 antibodies.

mAbs·2025
Same author

Neutralization of Marinobufagenin Demonstrates Efficacy In Vitro and In Vivo in Models of Pre-Eclampsia.

Biomedicines·2025

Related Experiment Video

Updated: Oct 26, 2025

Minimizing Hypoxia in Hippocampal Slices from Adult and Aging Mice
08:58

Minimizing Hypoxia in Hippocampal Slices from Adult and Aging Mice

Published on: July 2, 2020

7.9K

Response to Hypoxia in Cognitive Decline.

James W Larrick1, Jasmine W Larrick2, Andrew R Mendelsohn1

  • 1Panorama Research Institute and Regenerative Sciences Institute, Sunnyvale, California, USA.

Rejuvenation Research
|July 27, 2021
PubMed
Summary
This summary is machine-generated.

Aging

Keywords:
23-BPGagingcognitionhypoxiaoxygen

More Related Videos

Detection of Microregional Hypoxia in Mouse Cerebral Cortex by Two-photon Imaging of Endogenous NADH Fluorescence
12:03

Detection of Microregional Hypoxia in Mouse Cerebral Cortex by Two-photon Imaging of Endogenous NADH Fluorescence

Published on: February 21, 2012

16.2K
Author Spotlight: Improving Anesthesia Protocols for Enhanced Mouse Acupuncture Research
03:26

Author Spotlight: Improving Anesthesia Protocols for Enhanced Mouse Acupuncture Research

Published on: December 8, 2023

1.5K

Related Experiment Videos

Last Updated: Oct 26, 2025

Minimizing Hypoxia in Hippocampal Slices from Adult and Aging Mice
08:58

Minimizing Hypoxia in Hippocampal Slices from Adult and Aging Mice

Published on: July 2, 2020

7.9K
Detection of Microregional Hypoxia in Mouse Cerebral Cortex by Two-photon Imaging of Endogenous NADH Fluorescence
12:03

Detection of Microregional Hypoxia in Mouse Cerebral Cortex by Two-photon Imaging of Endogenous NADH Fluorescence

Published on: February 21, 2012

16.2K
Author Spotlight: Improving Anesthesia Protocols for Enhanced Mouse Acupuncture Research
03:26

Author Spotlight: Improving Anesthesia Protocols for Enhanced Mouse Acupuncture Research

Published on: December 8, 2023

1.5K

Area of Science:

  • Gerontology and cellular senescence
  • Neuroinflammation and metabolic dysfunction
  • Oxygen homeostasis and aging

Background:

  • Inflammaging, characterized by increased inflammation with age, involves cellular senescence and metabolic changes.
  • Aging-related alterations in oxygen metabolism, including reduced O2 levels and impaired hypoxia response, may worsen inflammaging.
  • Declining erythrocyte 2,3-bisphosphoglycerate (2,3-BPG) and related signaling pathways may compromise brain oxygenation during aging.

Purpose of the Study:

  • To explore the intricate relationship between oxygen metabolism, inflammaging, and cognitive health during the aging process.
  • To investigate the role of 2,3-BPG and adenosine signaling in protecting brain tissue from age-related hypoxia.
  • To identify potential therapeutic targets for mitigating age-related cognitive decline by restoring oxygen levels.

Main Methods:

  • Review of mechanisms linking aging, inflammation, and oxygen metabolism.
  • Analysis of the role of erythrocyte 2,3-BPG, BPG mutase, and adenosine A2B receptor in age-related hypoxia.
  • Discussion of the impact of reduced oxygen on microglia activation and endothelial cell senescence.

Main Results:

  • Decreased oxygen levels during aging, potentially due to dysfunction in oxygen metabolism, exacerbate inflammaging.
  • Reduced 2,3-BPG levels may impair the brain's ability to cope with subtle hypoxia, leading to neuroinflammation.
  • This process promotes endothelial cell senescence, contributing to the aging phenotype.

Conclusions:

  • Restoring oxygen levels or enhancing 2,3-BPG may be beneficial for cognitive health in aging.
  • Further research is needed to quantify age-related oxygen reduction in humans and mammals.
  • Targeting oxygen metabolism presents a promising avenue for combating age-related cognitive decline and inflammaging.